Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

SHANNON C TROTTER

Allopathic & Osteopathic Physicians Family Medicine

NPI
1124231154
CMS profile
232638
Location
SPRINGFIELD, OH

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$191,653.80

398 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Page 2 of 8; records 51–100 of 398 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

SHANNON C TROTTER

NPI 1124231154 · CMS profile ID 232638

Allopathic & Osteopathic Physicians / Family Medicine

SPRINGFIELD, OH

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 8; records 51–100 of 398 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1124231154?year=2025&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
SHANNON C TROTTER, NPI 1124231154, CMS profile ID 232638. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 8; records 51–100 of 398 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1124231154?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). SHANNON C TROTTER, NPI 1124231154, CMS profile ID 232638. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 8; records 51–100 of 398 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1124231154?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
SHANNON C TROTTER, NPI 1124231154, CMS profile ID 232638, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 8; records 51–100 of 398 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1124231154?year=2025&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

398 matching records · $191,653.80 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 398 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 398.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
ABBVIE INC. $1.3611/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204572202 CMS
ABBVIE INC. $21.0911/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204572194 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $14.8111/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251058349 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $2,500.0011/14/2025 Compensation for serving as faculty or as a speaker for a medical education program No dispute reported Delay: No
Change: NEW
06/30/2026 1251058289 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $2,500.0011/14/2025 Compensation for serving as faculty or as a speaker for a medical education program No dispute reported Delay: No
Change: NEW
06/30/2026 1251058329 CMS
LEO Pharma Inc. $23.3011/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1252040864 CMS
ABBVIE INC. $11.1411/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204572192 CMS
Botanix SB Inc $21.8811/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1246268277 CMS
Galderma Laboratories, L.P. $3.3011/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234712345 CMS
PFIZER INC. $1,354.4811/11/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1229763127 CMS
PFIZER INC. $8.9311/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229842402 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $3.3811/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251058297 CMS
ABBVIE INC. $6.7411/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204572186 CMS
PFIZER INC. $5,250.0011/10/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1230045533 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $2,500.0011/10/2025 Compensation for serving as faculty or as a speaker for a medical education program No dispute reported Delay: No
Change: NEW
06/30/2026 1251058287 CMS
PFIZER INC. $45.1811/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1230137881 CMS
Janssen Biotech, Inc. $67.9711/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174372140 CMS
UCB, Inc. $116.4111/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224418952 CMS
PFIZER INC. $5.1511/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229314993 CMS
PFIZER INC. $4,125.0011/06/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1229699091 CMS
Novartis Pharmaceuticals Corporation $26.6611/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200463360 CMS
PFIZER INC. $103.7511/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229525759 CMS
UCB, Inc. $0.5311/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224418948 CMS
UCB, Inc. $11.4811/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224418950 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $14.7411/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251058359 CMS
ABBVIE INC. $26.5910/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204572182 CMS
E.R. Squibb & Sons, L.L.C. $4.9010/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184823049 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $11.1710/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251058347 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $184.2210/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251058239 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $20.6810/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251058245 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $10.2610/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251058247 CMS
Janssen Biotech, Inc. $37.8610/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174371283 CMS
LEO Pharma Inc. $13.2410/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1252040860 CMS
LEO Pharma Inc. $39.3610/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1252040862 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $17.5410/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251058241 CMS
UCB, Inc. $32.2010/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224418946 CMS
Genentech, Inc. $35.2610/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1211588116 CMS
Incyte Corporation $37.5310/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226193095 CMS
Regeneron Healthcare Solutions, Inc. $10.2610/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1213060679 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $223.3610/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251058331 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $83.3210/22/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1251058333 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $3,000.0010/22/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1251058335 CMS
PFIZER INC. $4,275.0010/21/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1229172631 CMS
GENZYME CORPORATION $35.8710/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233447827 CMS
ABBVIE INC. $24.4010/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204572177 CMS
ABBVIE INC. $9.0010/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204572172 CMS
UCB, Inc. $26.3610/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224418944 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $2,500.0010/15/2025 Compensation for serving as faculty or as a speaker for a medical education program No dispute reported Delay: No
Change: NEW
06/30/2026 1251058285 CMS
Janssen Biotech, Inc. $94.9910/14/2025 Education No dispute reported Delay: No
Change: NEW
06/30/2026 1174372436 CMS
PFIZER INC. $4,125.0010/14/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1229567595 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $61,666.06 195
PY2020 $12,717.46 54
PY2021 $12,542.91 110
PY2022 $13,927.34 125
PY2023 $18,880.69 211
PY2024 $36,608.74 276
PY2025 $191,653.80 398

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $1,548.05 8
PY2025 Principal investigator $24,880.44 8
PY2024 Principal investigator $19,155.70 3

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

16 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $382.35 12/31/2025 Non-covered Recipient Entity
PROBITY MED RESEARCH CORPORATION
A Phase 3 randomized, placebo-controlled, double-blind program to evaluate efficacy and safety of upadacitinib in adult and adolescent subjects with severe alopecia areata No dispute reported 06/30/2026 1202533295
Principal investigator 1 ABBVIE INC. $3,035.24 12/04/2025 Non-covered Recipient Entity
DERMATOLOGISTS OF SW OHIO LLC
A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis (Start Up) No dispute reported 06/30/2026 1202527322
Principal investigator 1 ABBVIE INC. $2,306.91 11/05/2025 Non-covered Recipient Entity
DERMATOLOGISTS OF SW OHIO LLC
A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis (Start Up) No dispute reported 06/30/2026 1202521937
Principal investigator 1 ABBVIE INC. $5,026.25 10/09/2025 Non-covered Recipient Entity
DERMATOLOGISTS OF SW OHIO LLC
A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis (Start Up) No dispute reported 06/30/2026 1202514821
Principal investigator 1 ABBVIE INC. $2,162.13 09/04/2025 Non-covered Recipient Entity
DERMATOLOGISTS OF SW OHIO LLC
A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis (Start Up) No dispute reported 06/30/2026 1202509030
Recipient Regeneron Pharmaceuticals, Inc. $292.99 08/29/2025 Covered Recipient Physician A Phase 3 Randomized Study of Intralesional Cemiplimab Versus Primary Surgery in Participants With Early Stage Cutaneous Squamous Cell Carcinoma (CSCC) No dispute reported 06/30/2026 1184123570
Recipient Regeneron Pharmaceuticals, Inc. $196.67 08/29/2025 Covered Recipient Physician A Phase 3 Randomized Study of Intralesional Cemiplimab Versus Primary Surgery in Participants With Early Stage Cutaneous Squamous Cell Carcinoma (CSCC) No dispute reported 06/30/2026 1184123572
Recipient Regeneron Pharmaceuticals, Inc. $60.13 08/29/2025 Covered Recipient Physician A Phase 3 Randomized Study of Intralesional Cemiplimab Versus Primary Surgery in Participants With Early Stage Cutaneous Squamous Cell Carcinoma (CSCC) No dispute reported 06/30/2026 1184123574
Recipient Regeneron Pharmaceuticals, Inc. $26.73 08/29/2025 Covered Recipient Physician A Phase 3 Randomized Study of Intralesional Cemiplimab Versus Primary Surgery in Participants With Early Stage Cutaneous Squamous Cell Carcinoma (CSCC) No dispute reported 06/30/2026 1184123576
Recipient Regeneron Pharmaceuticals, Inc. $73.50 08/29/2025 Covered Recipient Physician A Phase 3 Randomized Study of Intralesional Cemiplimab Versus Primary Surgery in Participants With Early Stage Cutaneous Squamous Cell Carcinoma (CSCC) No dispute reported 06/30/2026 1184123578
Recipient Regeneron Pharmaceuticals, Inc. $2.34 08/29/2025 Covered Recipient Physician A Phase 3 Randomized Study of Intralesional Cemiplimab Versus Primary Surgery in Participants With Early Stage Cutaneous Squamous Cell Carcinoma (CSCC) No dispute reported 06/30/2026 1184123580
Recipient Regeneron Pharmaceuticals, Inc. $49.44 08/29/2025 Covered Recipient Physician A Phase 3 Randomized Study of Intralesional Cemiplimab Versus Primary Surgery in Participants With Early Stage Cutaneous Squamous Cell Carcinoma (CSCC) No dispute reported 06/30/2026 1184123582
Recipient Regeneron Pharmaceuticals, Inc. $846.25 08/12/2025 Covered Recipient Physician A Phase 3 Randomized Study of Intralesional Cemiplimab Versus Primary Surgery in Participants With Early Stage Cutaneous Squamous Cell Carcinoma (CSCC) No dispute reported 06/30/2026 1184123568
Principal investigator 1 ABBVIE INC. $7,620.19 08/06/2025 Non-covered Recipient Entity
DERMATOLOGISTS OF SW OHIO LLC
A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis (Start Up) No dispute reported 06/30/2026 1202503093
Principal investigator 1 ABBVIE INC. $100.00 06/03/2025 Non-covered Recipient Entity
DERMATOLOGISTS OF SW OHIO LLC
A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis (Start Up) No dispute reported 06/30/2026 1202488811
Principal investigator 1 Amgen Inc. $4,247.37 01/02/2025 Non-covered Recipient Entity
DERMATOLOGIST OF CENTRAL STATES CLINICAL RESEARCH - SPRINGFIELD
A Phase 3, Multicenter, Double-blind Maintenance Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-ASCEND) No dispute reported 06/30/2026 1246640697